Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers



Status:Completed
Conditions:Cancer, Cancer, Blood Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 120
Updated:10/10/2018
Start Date:October 10, 2008
End Date:March 17, 2015

Use our guide to learn which trials are right for you!

The Pilot Palliative ARNP (Advanced Registered Nurse Practitioner) Liaison Program (The PAL Program): Improving Communication Between Patients, Oncologists, and Hospice, Promoting Timely Hospice Referrals and Bringing Education and Research Efforts to Hospice and Palliative Care

RATIONALE: Gathering information about patients with terminal metastatic cancer may help
doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not
yet known whether a nurse practitioner program helps increase patients' length of stay in
hospice.

PURPOSE: This randomized research study is evaluating a nurse practitioner hospice program
for patients with terminal metastatic cancer and their families or caregivers.

OBJECTIVES:

Primary

- To assess the effect of the palliative advanced registered nurse practitioner liaison
program (PAL) on length of patient's enrollment in hospice care.

Secondary

- To evaluate the impact of the PAL program on patient's knowledge about hospice services.

- To evaluate the impact of the PAL program on patient and family or caregiver's
psychological stress during palliative treatments.

OUTLINE: Patients are randomized to 1 of 2 arms.

- Arm I (advanced registered nurse practitioner [ARNP] intervention): Patients and their
families or caregiver receive information from an ARNP about terminal cancer, resources
available for supportive care, and the benefits of palliative care. After transition to
hospice, patients receive pain and palliative medicine, psychology, social services,
chaplaincy, and patient support group intervention arranged by the ARNP. Patients
complete the Patient Questionnaire about overall quality of life and mental, emotional,
and physical well being at baseline and at 3 weeks after intervention or at time of
enrollment in hospice. Patients and their families or caregivers are contacted by the
ARNP weekly.

- Arm II (no ARNP intervention): Patients and their families or caregivers complete the
same Patient Questionnaire, administered by a clinical research assistant (CRA), as in
Arm I. Patients and their families or caregivers receive no ARNP intervention. After
transition to hospice, patients receive routine hospice care.

Patients participate in this study for a duration of 21 days while in hospice care. At the
completion of the study, patients in both arms complete questionnaires about pain management,
social, emotional, and spiritual and mental well-being. Patients' families or caregivers
complete the Caregiver Questionnaire and the Hospice Family Satisfaction Survey 3 weeks after
patient's death.

DISEASE CHARACTERISTICS:

- Diagnosis of terminal metastatic cancer

- Patient at Mayo Clinic in Jacksonville, Florida

- Strong candidate for hospice care

- Entering or planning to enter Community Hospice of Northeast Florida

- Willing to undergo visits by an Advanced Registered Nurse Practitioner (ARNP)
after hospice enrollment

PATIENT CHARACTERISTICS:

- Willing to participate in 2 palliative care consultations with an ARNP prior to
hospice enrollment

- Life expectancy < 12 months

- Able to complete questionnaires with or without assistance

- Has a primary caregiver with an identified relationship to the patient

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics
We found this trial at
1
site
Jacksonville, Florida 32216
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials